Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

BIOmarkers and PREDISC Diagnostic Evaluation for Patients With Suspected Transient Ischemic Attacks: the BIOPREDISC- TIA SWISS Cohort Study

NCT03994003 is registered in ClinicalTrials.gov with Dr. med. Carlo Cereda as lead sponsor.

NCT NCT03994003
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03994003 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
BIOmarkers and PREDISC Diagnostic Evaluation for Patients With Suspected Transient Ischemic Attacks: the BIOPREDISC- TIA SWISS Cohort Study
Lead sponsor
Dr. med. Carlo Cereda
Phase
Observational
Overall status
Completed
Start date
August 4, 2017
Completion date
December 31, 2021
Enrollment
64 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

cerebrovascular disease, ischemic stroke